Cite
HARVARD Citation
Li, M. et al. (2022). Nintedanib exerts anti-pulmonary fibrosis activity via inhibiting TANK-binding kinase 1 (TBK1) phosphorylation. Chemical communications. 58 (8), pp. 1199-1202. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Li, M. et al. (2022). Nintedanib exerts anti-pulmonary fibrosis activity via inhibiting TANK-binding kinase 1 (TBK1) phosphorylation. Chemical communications. 58 (8), pp. 1199-1202. [Online].